Publications

Antimicrobial resistance and COVID-19: Intersections and implications.

KNIGHT, GM; GLOVER, RE; MCQUAID, CF; OLARU, ID; GALLANDAT, K; LECLERC, QJ; FULLER, NM; WILLCOCKS, SJ; Hasan, R; Van Kleef, E; CHANDLER, CI;

2021

eLife, (2021).10, 10.7554/eLife.64139.

Trust and transparency in times of crisis: Results from an online survey during the first wave (April 2020) of the COVID-19 epidemic in the UK.

ENRIA, L; WATERLOW, N; ROGERS, NT; BRINDLE, H; LAL, S; EGGO, RM; LEES, S; ROBERTS, CH;

2021

PLoS One, (2021).16 2 10.1371/journal.pone.0239247.

Time to evaluate COVID-19 contact-tracing apps.

Colizza, V; Grill, E; Mikolajczyk, R; Cattuto, C; KUCHARSKI, A; Riley, S; Kendall, M; Lythgoe, K; Bonsall, D; Wymant, C; Abeler-Dörner, L; Ferretti, L; Fraser, C;

2021

Nature medicine, (2021).27 3 10.1038/s41591-021-01236-6.

Testing for SARS-CoV-2 at the core of voluntary collective isolation: Lessons from the indigenous populations living in the Amazon region in Ecuador.

Ortiz-Prado, E; Rivera-Olivero, IA; Freire-Paspuel, B; LOWE, R; Lozada, T; Henriquez-Trujillo, AR; Garcia-Bereguiain, MA; UDLA COVID-19 Team,;

2021

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, (2021).105, 10.1016/j.ijid.2021.02.039.

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.

Wouters, OJ; Shadlen, KC; Salcher-Konrad, M; Pollard, AJ; LARSON, HJ; Teerawattananon, Y; JIT, M;

2021

Lancet (London, England), (2021).397 10278 10.1016/S0140-6736(21)00306-8.

Adaptation and performance of a mobile application for early detection of cutaneous leishmaniasis.

Rubiano, L; ALEXANDER, ND E; Castillo, RM; Martínez, ÁJ; García Luna, JA; Arango, JD; Vargas, L; Madriñán, P; Hurtado, L-R; Orobio, Y; Rojas, CA; Del Corral, H; Navarro, A; Gore Saravia, N; Aronoff-Spencer, E;

2021

PLoS neglected tropical diseases, (2021).15 2 10.1371/journal.pntd.0008989.

Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7.

DAVIES, NG; JARVIS, CI; CMMID COVID-19 Working Group,; EDMUNDS, WJ; JEWELL, NP; DIAZ-ORDAZ, K; KEOGH, RH;

2021

Nature, (2021).593 7858 10.1038/s41586-021-03426-1.

Who should be prioritized for COVID-19 vaccination in China? A descriptive study.

Yang, J; Zheng, W; Shi, H; Yan, X; Dong, K; You, Q; Zhong, G; Gong, H; Chen, Z; JIT, M; Viboud, C; Ajelli, M; Yu, H;

2021

BMC medicine, (2021).19 1 10.1186/s12916-021-01923-8.

Epidemiology of dengue fever in Gabon: Results from a health facility-based fever surveillance in Lambaréné and its surroundings.

Lim, JK; Fernandes, JF; Yoon, I-K; Lee, J-S; Mba, RO; Lee, KS; Namkung, S; Yang, JS; Bae, SH; Lim, S-K; Lell, B; Esen, M; Loembe, MM; Kremsner, PG; ALEXANDER, N; Agnandji, ST;

2021

PLoS neglected tropical diseases, (2021).15 2 10.1371/journal.pntd.0008861.

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.

AFOLABI, MO; ISHOLA, D; MANNO, D; Keshinro, B; Bockstal, V; Rogers, B; Owusu-Kyei, K; Serry-Bangura, A; Swaray, I; Lowe, B; Kowuor, D; Baiden, F; Mooney, T; Smout, E; Köhn, B; Otieno, GT; Jusu, M; Foster, J; Samai, M; Deen, GF; LARSON, H; LEES, S; Goldstein, N; GALLAGHER, KE; Gaddah, A; ... EBL3001 study group,

2021

Lancet Infectious Diseases, (2021).22 1 10.1016/S1473-3099(21)00128-6.